Stay updated on Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The website's revision label was updated from v3.8.0 to v3.8.1.
    Difference
    0.0%
    Check dated 2026-11-18T02:43:39.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The clinical trial record is now available, including study details, eligibility criteria, locations, treatment arms, outcome measures, publications, and study documents for CheckMate 743.
    Difference
    100%
    Check dated 2026-11-11T01:47:45.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0; the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-04T00:06:30.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    A site-wide banner announces an NIH terminology transition, and the site revision number changes from v3.7.1 to v3.7.2. The study page continues to display a 403 error.
    Difference
    1%
    Check dated 2026-10-21T00:10:19.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page remains a 403 Forbidden error, while the footer’s site revision changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T00:15:59.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden message instead of the expected study details. This change blocks access to the trial information and replaces it with a generic error page, altering how users interact with the page in this context.
    Difference
    18%
    Check dated 2026-09-23T00:15:52.000Z thumbnail image

Stay in the know with updates to Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial page.